Adaptimmune Therapeutics
ADAP
#9234
Rank
โ‚ฌ64.26 M
Marketcap
0,24ย โ‚ฌ
Share price
4.45%
Change (1 day)
-77.43%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Adaptimmune Therapeutics CIK: 0001621227

Thumbnail Adaptimmune Therapeutics 20-F Annual Report

20-F Annual Report 2016-03-17

Language: English

View Annual Report (20-F)
Thumbnail Adaptimmune Therapeutics 20-F Annual Report

20-F Annual Report 2015-10-13

Language: English

View Annual Report (20-F)